Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Jun 1:10:1195263.
doi: 10.3389/fmed.2023.1195263. eCollection 2023.

Editorial: Idiopathic pulmonary fibrosis: epidemiology, prognosis and treatment

Antonella Caminati  1 , Federica Meloni  2 , Masaki Fujita  3
Affiliations
Editorial

Editorial: Idiopathic pulmonary fibrosis: epidemiology, prognosis and treatment

Antonella Caminati et al. Front Med (Lausanne). .
No abstract available

Keywords: IPF; epidemiology; gender; genetic predisposition; therapy.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Comment on

  • Editorial on the Research Topic Idiopathic pulmonary fibrosis: epidemiology, prognosis and treatment

References

    1. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, et al. . An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. (2011) 183:788–824. 10.1164/rccm.2009-040GL - DOI - PMC - PubMed
    1. Lee J, Arisi I, Puxeddu E, Mramba LK, Amicosante M, Swaisgood CM, et al. . Bronchoalveolar lavage (BAL) cells in idiopathic pulmonary fibrosis express a complex pro-inflammatory, pro-repair, angiogenic activation pattern, likely associated with macrophage iron accumulation. PLoS ONE. (2018) 13:e0194803. 10.1371/journal.pone.0194803 - DOI - PMC - PubMed
    1. Podolanczuk AJ, Raghu G, Tsai MY, Kawut SM, Peterson E, Sonti R, et al. . Cholesterol, lipoproteins and subclinical interstitial lung disease: the MESA study. Thorax. (2017) 72:472–4. 10.1136/thoraxjnl-2016-209568 - DOI - PMC - PubMed
    1. Bekkering S, Arts RJW, Novakovic B, Kourtzelis I, van der Heijden CDCC, Li Y, et al. . Metabolic induction of trained immunity through the mevalonate pathway. Cell. (2018) 172:135–46.e9. 10.1016/j.cell.2017.11.025 - DOI - PubMed
    1. Agur T, Wedel J, Bose S, Sahankumari AGP, Goodman D, Kong SW, et al. . Inhibition of mevalonate metabolism by statins augments the immunoregulatory phenotype of vascular endothelial cells and inhibits the costimulation of CD4+ T cells. Am J Transplant. (2022) 22:947–54. 10.1111/ajt.16872 - DOI - PubMed

Publication types

LinkOut - more resources